83195-24-8

Usage

Uses

Used in the Food Industry:
1-(2-hydroxy-3-phenoxypropyl)pyrrolidine-2,5-dione is used as an additive for its antioxidant properties to enhance the shelf life of food products and prevent oxidation, which can lead to spoilage and loss of nutritional value.
Used in the Cosmetic Industry:
In the cosmetic industry, 1-(2-hydroxy-3-phenoxypropyl)pyrrolidine-2,5-dione is used as an ingredient in anti-aging products due to its potent antioxidant capabilities, which can help protect the skin from free radical damage and promote a youthful appearance.
Used in the Pharmaceutical Industry:
1-(2-hydroxy-3-phenoxypropyl)pyrrolidine-2,5-dione is used as a chelating agent in the development of pharmaceutical products, particularly those that require stabilization against metal-catalyzed oxidation or that involve metal ion interactions for their therapeutic effects.

Upstream product

• 123-56-8 Succinimide 
• 122-60-1 Phenyl glycidyl ether 
• 108-95-2 phenol 

Downstream Products

• 83194-85-8 3-(2-Hydroxy-3-phenoxy-propylamino)-propionic acid ethyl ester 
• 4287-20-1 d,l-1-Phenoxy-2-hydroxy-3-aminopropane hydrochloride 

Relevant academic research and scientific papers

NOVEL DIPEPTIDYL-PEPTIDASE-IV INHIBITORS

The invention comprises novel inhibitors of dipeptidyl peptidase IV (DPP-IV) with beta blocker activity, pharmaceutical compositions comprising therapeutically effective amounts of novel inhibitors of DPP-IV, and novel methods of treating medical conditio

COMPOUNDS AND METHOD FOR TREATMENT OR PROPHYLAXIS OF CARDIAC DISOREDRS

A short-acting β-blocking compound of the formula STR1 wherein Ar may be substituted or unsubstituted aromatic, Y may be a straight or branched carbon chain or aralkyl, R may be lower alkyl, lower alkenyl, lower alkynyl, aryl or aralkyl, and x is an integer from 1 to about 3; or a pharmaceutically acceptable salt thereof.

Ultra-short-acting β-adrenergic receptor blocking agents. I. (Aryloxy)propanolamines containing esters in the nitrogen substituent

In an attempt to produce short-acting β-adrenergic receptor blocking agents, we prepared several (aryloxy)propanolamines with ester functions incorporated into the nitrogen substituent. Many of these compounds exhibited a short duration of blocking activity after their continuous intravenous infusion for 40 min. However, their durations were found to increase considerably upon longer intravenous infusion.